Brief: Kaleido Biosciences Announces Presentation Of Data For Therapies For Hyperammonemia
12/04/2019 12:56
April 12 (Reuters) - Kaleido Biosciences Inc KLDO.O :
* KALEIDO BIOSCIENCES ANNOUNCES PRESENTATION OF CLINICAL
STUDY AND
EX VIVO DATA SUPPORTING THE DEVELOPMENT OF NOVEL MICROBIOME
METABOLIC THERAPIES FOR HYPERAMMONEMIA AT THE INTERNATIONAL
LIVER CONGRESS™ 2019 (EASL)
Source text for Eikon: ID:nGNXbHL5fs
Further company coverage: KLDO.O
((Reuters.Briefs@thomsonreuters.com;))